Crispr Therapeutics Ag (CRSP)

SG&A Expenses

$67.97M

TTM · Period ending: · USD

CRSP logo

CRSP SG&A Expenses

Latest reported$67.97M
CRSP TTM SG&A Expenses ($13.40M → $67.97M)
High-resolution chart · PNG

CRSP sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
67,966,000
71,429,000
73,542,000
73,267,000
73,755,000
74,320,000
72,977,000
71,332,000
72,204,000
71,755,000
76,162,000
80,852,000
89,562,000
96,803,000
102,464,000
104,973,000
101,681,000
104,214,000
100,710,000
102,798,000
100,628,000
93,175,000
88,208,000
79,714,000
73,694,000
68,109,000
63,488,000
62,758,000
57,414,000
54,387,000
48,294,000
43,075,000
41,012,000
36,039,000
35,845,000
36,604,000
32,599,000
33,582,000
31,056,000
25,213,000
23,559,000
16,947,000
13,403,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.